← Back to Patent Explorer
US4242505A Expired / Lapsed US ⏱️ 0.0 years remaining

S-Adenosyl-L-methionine compositions and production thereof

Assignee: Yamasa Shoyu KK
•
Filing: 1978-07-28
•
Granted: 1980-12-30
•
Expires: 1998-07-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract S-adenosyl-L-methionine compositions stabilized against decomposition of S-adenosyl-L-methionine comprising S-adenosyl-L-methionine, a sulfuric acid equivalent and a nucleoside sulfate, which are produced from a solution comprising the three essential components in an aqueous solvent by, for example, adding thereto a water-miscible organic solvent thereby to precipitate the composition (process A) and/or by evaporating the aqueous solvent off the solution (process B).

Inventors

  • 👤 Toshihisa Kawahara
  • 👤 Goro Motoki

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 17:47
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/16; G; G11; G11B; G11B27/00

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 18 words
An S-adenosyl-L-methionine composition stabilized against decomposition of S-adenosyl-L-methionine comprising S-adenosyl-L-methionine, a sulfuric acid equivalent, and a nucleoside sulfate.
Claim 2
Dependent Claim 18 words
An S-adenosyl-L-methionine composition stabilized against decomposition of S-adenosyl-L-methionine comprising S-adenosyl-L-methionine, a sulfuric acid equivalent, and a nucleoside sulfate.
Claim 3
Dependent Claim 42 words
The composition as set forth in claim 1, in which the molar ratio of the components is 1 part of S-adenosyl-L-methionine to from 1 to 3 parts of the sulfuric acid equivalent to not less than 0.5 part of the nucleoside sulfate.
Claim 4
Dependent Claim 31 words
The composition as set forth in claim 1, in which the nucleoside sulfate is a member selected from the group consisting of a nucleoside monosulfate, a nucleoside disulfate, and mixtures thereof.
Claim 5
Dependent Claim 43 words
The composition as set forth in claim 3, in which the nucleoside monosulfate is a member selected from the group consisting of inosine-5'-monosulfate, adenosine-5'-monosulfate, guanosine-5'-monosulfate, uridine-5'-monosulfate, cytidine-5'-monosulfate, xanthosine-5'-monosulfate,thymidine-5'-monosulfate, deoxyguanosine-5'-monosulfate, deoxyinosine-5'-monosulfate, inosine-2'(3')-monosulfate, adenosine-2'(3')-monosulfate, guanosine-2'(3')-monosulfate, cytidine-2'(3')-monosulfate, uridine-2')3')-monosulfate, thymidine-3'-monosulfate, deoxyinosine-3'-monosulfate, deoxyadenosine-3'-monosulfate, deoxyguanosine-3'-monosulfate, deoxycytidine-3'-monosulfate, and mixtures thereof.
Claim 6
Dependent Claim 43 words
The composition as set forth in claim 3, in which the nucloside disulfate is a member selected from the group consisting of inosine-2'(3'),5'-disulfate, adenosine-2'(3'),5'-disulfate, guanosine-2'(3'),5'-disulfate, xanthosine-2'(3'),5'-disulfate, uridine-2'(3'),5'-disulfate, cytidine-2'(3'),5'-disulfate, thymidine-3',5'-disulfate, deoxyinosine-3',5'-disulfate, deoxyadenosine-3',5'-disulfate, deoxyguanosine-3',5'-disulfate deoxyxanthosine-3',5'-disulfate, deoxycytidine-3',5'-disulfate, adenosine-2',3'-disulfate, inosine-2',3'-disulfate, guanosine-2',3'-disulfate, xanthosine-2',3'-disulfate, cytidine-2',3'-disulfate, uridine-2',3'-disulfate, and mixtures thereof.
Claim 7
Dependent Claim 31 words
The composition as set forth in claim 2, in which the nucleoside sulfate is a member selected from the group consisting of a nucleoside monosulfate, a nucleoside disulfate, and mixtures thereof.
Claim 8
Dependent Claim 44 words
The composition as set forth in claim 6, in which the nucleoside monosulfate is a member selected from the group consisting of inosine-5'-monosulfate, adenosine-5'-monosulfate, guanosine-5'-monosulfate, uridine-5'-monosulfate, cytidine-5'-monosulfate, xanthosine-5'-monosulfate, thymidine-5'-monosulfate, deoxyguanosine-5'-monosulfate, deoxyinosine-5'-monosulfate, inosine-2'(3')-monosulfate, adenosine-2'(3')-monosulfate, guanosine-2'(3')-monosulfate, cytidine-2'(3')-monosulfate, uridine-2'(3')-monosulfate, thymidine-3'-monosulfate, deoxyinosine-3'-monosulfate, deoxyadenosine-3'-monosulfate, deoxyguanosine-3'-monosulfate, deoxycytidine-3'-monosulfate, and mixtures thereof.
Claim 9
Dependent Claim 43 words
The composition as set forth in claim 6, in which the nucloside disulfate is a member selected from the group consisting of inosine-2'(3'),5'-disulfate, adenosine-2'(3'),5'-disulfate, guanosine-2'(3'),5'-disulfate, xanthosine-2'(3'),5'-disulfate, uridine-2'(3'),5'-disulfate, cytidine-2'(3'),5'-disulfate, thymidine-3',5'-disulfate, deoxyinosine-3',5'-disulfate, deoxyadenosine-3',5'-disulfate, deoxyguanosine-3',5'-disulfate, deoxyxanthosine-3',5'-disulfate, deoxycytidine-3',5'-disulfate, adenosine-2',3'-disulfate, inosine-2',3'-disulfate, guanosine-2',3'-disulfate, xanthosine-2',3'-disulfate, cytidine-2',3'-disulfate, uridine-2',3'-disulfate, and mixtures thereof.

References Cited (Backward Citations)

US3954726A Cited
US4057686A Cited
US4109079A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-12-30 1984-06-30 1984-12-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-12-30 1988-06-30 1988-12-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-12-30 1992-06-30 1992-12-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag